Allena Pharmaceuticals

+$0.0222 (+3.49%) Today
-$0.002 (-0.30%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNA and other ETFs, options, and stocks.

About ALNA

Allena Pharmaceuticals, Inc. engages in the development, discovery and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria in adults and ALLN-346, which is used for patients with hyperuricemia and moderate to severe chronic kidney disease.

CEO
Louis Brenner
Employees
41
Headquarters
Newton, Massachusetts
Founded
2011

ALNA Key Statistics

Market cap
54.33M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.62M
High today
$0.67
Low today
$0.6227
Open price
$0.6362
Volume
1.06M
52 Week high
$2.78
52 Week low
$0.6227

ALNA Earnings

-$0.45
-$0.30
-$0.15
-$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure